Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
GDTC

Updated 10/6/2026, 11:57 AM ET.

GDTC

CytoMed Therapeutics Ltd

Buy$300,000

Choo Chee Kong

Director, 10% owner

200,000 shat $1.50Filed Jul 24, 9:01 PM ET
Amended
Filing
GDTC

CytoMed Therapeutics Ltd

Buy$300,000

Choo Chee Kong

Director, 10% owner

200,000 shat $1.50Filed Jul 24, 12:33 PM ETFiling

Read from public SEC filings. Not financial advice.